Diabetomics Lumella - Blood Test Kit for Early Detection of Preeclampsia

The Lumella® Test, The New Point-of-Care Blood Test Helps in Early Detection of Preeclampsia; The Lumella® test estimates the concentration of Glycosylated Fibronectin, a new pregnancy specific biomarker to accurately assess the risk of preeclampsia. The Lumella® test requires a simple finger stick and can be performed in physician’s office/clinic in the first, second, or third trimesters, between 13 to 37 weeks of gestation.